The Highly Potent Active Pharmaceutical Ingredients Online Summit is back with its 7th edition.

HPAPI manufacturing is a rapidly growing industry that presents important challenges to the production site. The health of the operators (OEL > 1mg/m3) and patients (fewer side effects) is the main priority for the businesses, as well as caring for the environment and rational optimisation at high containment facilities.

Join us and learn about the latest market development trends and safety perspectives on handling highly potent APIs and many other interesting topics, including how the contract manufacturing organisation (CMO/CDMO) works and the solutions for control, new regulatory compliance challenges in 2022, and more.